Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Karmanos Cancer Institute Wayne St Karmanos
mi
from
Detroit, MI
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Karmanos Cancer Institute Wayne St Karmanos
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Washington University School of Medicine Washington University (16)
mi
from
St. Louis, MO
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Washington University School of Medicine Washington University (16)
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Memorial Sloan Kettering Cancer Center Sloan Kettering
mi
from
NY, NY
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Memorial Sloan Kettering Cancer Center Sloan Kettering
mi
from
NY, NY
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Texas Oncology South Texas Oncology
mi
from
Dallas, TX
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Texas Oncology South Texas Oncology
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Novartis Investigative Site
mi
from
Rio Negro,
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Novartis Investigative Site
mi
from
Rio Negro,
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Birmingham, AL
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Aurora, CO
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Orange, CA
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
San Francisco, CA
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Boynton Beach, FL
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Tampa, FL
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Wichita, KA
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Bethlehem, PA
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated:  3/10/2016
#216
mi
from
Blacktown,
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
Status: Enrolling
Updated: 3/10/2016
#216
mi
from
Blacktown,
Click here to add this to my saved trials
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
Status: Enrolling
Updated:  3/10/2016
UNC Hospitals
mi
from
Chapel Hill, NC
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
Status: Enrolling
Updated: 3/10/2016
UNC Hospitals
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Ocean Medical Center
mi
from
Brick, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Ocean Medical Center
mi
from
Brick, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Bayshore Community Hospital
mi
from
Holmdel, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Bayshore Community Hospital
mi
from
Holmdel, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Southern Ocean Medical Center
mi
from
Manahawkin, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Southern Ocean Medical Center
mi
from
Manahawkin, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Riverview Medical Center
mi
from
Red Bank, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Riverview Medical Center
mi
from
Red Bank, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Somerset Medical Center
mi
from
Somerville, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Somerset Medical Center
mi
from
Somerville, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Cooper Hospital University Medical Center
mi
from
Camden, NJ
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Cooper Hospital University Medical Center
mi
from
Camden, NJ
Click here to add this to my saved trials
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated:  3/10/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Decisional Aid Intervention for Women Considering Breast Reconstruction
Decisional Aid Intervention for Women Considering Breast Reconstruction
Status: Enrolling
Updated: 3/10/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
Multimodality Imaging Assessment of Sipuleucel T Treatment and in Vivo Immune Response of Metastatic Castration Resistant Prostate Cancer Patients
Status: Enrolling
Updated:  3/10/2016
New York University Cancer Center
mi
from
New York, NY
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
Multimodality Imaging Assessment of Sipuleucel T Treatment and in Vivo Immune Response of Metastatic Castration Resistant Prostate Cancer Patients
Status: Enrolling
Updated: 3/10/2016
New York University Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated:  3/10/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated: 3/10/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated:  3/10/2016
Barbara Ann Karmanos Cancer Center
mi
from
Detroit, MI
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated: 3/10/2016
Barbara Ann Karmanos Cancer Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated:  3/10/2016
Charite -Universitätsmedizin Berlin
mi
from
Berlin,
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated: 3/10/2016
Charite -Universitätsmedizin Berlin
mi
from
Berlin,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated:  3/10/2016
Albert Einstein Comprehensive Cancer Center
mi
from
Bronx, NY
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated: 3/10/2016
Albert Einstein Comprehensive Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated:  3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated: 3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated:  3/10/2016
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated: 3/10/2016
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated:  3/10/2016
Mount Sinai Medical Center, NY
mi
from
New York, NY
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated: 3/10/2016
Mount Sinai Medical Center, NY
mi
from
New York, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated:  3/10/2016
New York Medical College
mi
from
Valhalla, NY
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin
Status: Enrolling
Updated: 3/10/2016
New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer
Status: Enrolling
Updated:  3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer
Status: Enrolling
Updated: 3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Chemotherapy in Treating Patients With Breast Cancer
Phase I/II Clinical and Pharmacological Study of Liposomal Annamycin in Anthracycline-Resistant Breast Cancer
Status: Enrolling
Updated:  3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Chemotherapy in Treating Patients With Breast Cancer
Phase I/II Clinical and Pharmacological Study of Liposomal Annamycin in Anthracycline-Resistant Breast Cancer
Status: Enrolling
Updated: 3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
Lymphoscintigraphy Assisted Molecular Staging of Head and Neck Cancer
Status: Enrolling
Updated:  3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
Lymphoscintigraphy Assisted Molecular Staging of Head and Neck Cancer
Status: Enrolling
Updated: 3/10/2016
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer
Phase-II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma (R0 Resection and at Least D1 Lymph-node Dissection)
Status: Enrolling
Updated:  3/10/2016
Bellevue Hospital
mi
from
New York, NY
Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer
Phase-II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma (R0 Resection and at Least D1 Lymph-node Dissection)
Status: Enrolling
Updated: 3/10/2016
Bellevue Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer
Phase-II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma (R0 Resection and at Least D1 Lymph-node Dissection)
Status: Enrolling
Updated:  3/10/2016
NYU Cancer Center
mi
from
New York, NY
Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer
Phase-II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma (R0 Resection and at Least D1 Lymph-node Dissection)
Status: Enrolling
Updated: 3/10/2016
NYU Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer
Phase-II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma (R0 Resection and at Least D1 Lymph-node Dissection)
Status: Enrolling
Updated:  3/10/2016
NYU Tisch Hospital
mi
from
New York, NY
Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer
Phase-II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma (R0 Resection and at Least D1 Lymph-node Dissection)
Status: Enrolling
Updated: 3/10/2016
NYU Tisch Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance
Impact of C-arm CT in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transhepatic Arterial Chemoembolization (TACE): Optimal Imaging Guidance
Status: Enrolling
Updated:  3/10/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance
Impact of C-arm CT in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transhepatic Arterial Chemoembolization (TACE): Optimal Imaging Guidance
Status: Enrolling
Updated: 3/10/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated:  3/10/2016
Florida Cancer Specialists
mi
from
Fort Myers, FL
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 3/10/2016
Florida Cancer Specialists
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated:  3/10/2016
Integrated Community Oncology Network, LLC
mi
from
Jacksonville, FL
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 3/10/2016
Integrated Community Oncology Network, LLC
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated:  3/10/2016
Florida Hospital Cancer Institute
mi
from
Orlando, FL
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 3/10/2016
Florida Hospital Cancer Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated:  3/10/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 3/10/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated:  3/10/2016
Consultants in Blood Disorders and Cancer
mi
from
Louisville, KY
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 3/10/2016
Consultants in Blood Disorders and Cancer
mi
from
Louisville, KY
Click here to add this to my saved trials
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated:  3/10/2016
Oncology Hematology Care
mi
from
Cincinnati, OH
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 3/10/2016
Oncology Hematology Care
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated:  3/10/2016
Consultants in Medical Oncology and Hematology, PC
mi
from
Drexel Hill, PA
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 3/10/2016
Consultants in Medical Oncology and Hematology, PC
mi
from
Drexel Hill, PA
Click here to add this to my saved trials